Aimei Health Technology Co., Ltd (NASDAQ:AFJK) is Wealthspring Capital LLC’s 2nd Largest Position

Wealthspring Capital LLC cut its stake in Aimei Health Technology Co., Ltd (NASDAQ:AFJK) by 10.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 479,050 shares of the company’s stock after selling 55,060 shares during the quarter. Aimei Health Technology accounts for about 6.2% of Wealthspring Capital LLC’s investment portfolio, making the stock its 2nd largest holding. Wealthspring Capital LLC owned 5.31% of Aimei Health Technology worth $5,020,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Robinson Capital Management LLC bought a new stake in shares of Aimei Health Technology during the 1st quarter valued at about $123,000. Virtu Financial LLC purchased a new stake in Aimei Health Technology during the first quarter valued at approximately $190,000. Clear Street LLC bought a new position in Aimei Health Technology in the second quarter worth approximately $575,000. Periscope Capital Inc. bought a new stake in shares of Aimei Health Technology during the 1st quarter valued at $1,536,000. Finally, Mizuho Securities USA LLC purchased a new stake in shares of Aimei Health Technology in the 1st quarter worth $2,724,000. Institutional investors own 45.58% of the company’s stock.

Aimei Health Technology Stock Performance

Aimei Health Technology stock remained flat at $10.61 during trading on Friday. The company had a trading volume of 46 shares, compared to its average volume of 50,773. The business’s 50 day moving average is $10.47 and its 200-day moving average is $10.38. Aimei Health Technology Co., Ltd has a one year low of $10.15 and a one year high of $10.60.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.